[1] |
Kataoka H, Yasuda S, Fukaya S, et al. Decreased of Runx1 and lowered proportion of Foxp3+CD25+ CD4+ regulatory T cells in systemic sclerosis[J]. Mod Rheumatol, 2015,25(1):90⁃95. doi: 10.3109/14397595.2014.899736.
|
[2] |
Niu Q, Cai B, Huang ZC, et al. Disturbed Th17/Treg balance in patients with rheumatoid arthritis[J]. Rheumatol Int, 2012,32(9):2731⁃2736. doi: 10.1007/s00296⁃011⁃1984⁃x.
|
[3] |
Quaglino P, Ponti R, Novelli M, et al. Flow cytometric analyses of circulating regulatory T cells in patients with dermatitis herpetiformis and other immune mediated dermatoses[J]. G Ital Dermatol Venereol, 2013,148(2):197⁃201.
|
[4] |
Walker MR, Kasprowicz DJ, Gersuk VH, et al. Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25⁃ T cells[J]. J Clin Invest, 2003,112(9):1437⁃1443. doi: 10.1172/JCI19441.
|
[5] |
Brunkow ME, Jeffery EW, Hjerrild KA, et al. Disruption of a new forkhead/winged⁃helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse[J]. Nat Genet, 2001,27(1):68⁃73. doi: 10.1038/83784.
|
[6] |
Janson PC, Winerdal ME, Marits P, et al. FOXP3 promoter demethylation reveals the committed Treg population in humans[J/OL]. PLoS One, 2008,3(2):e1612[2017⁃03⁃15]. https://journals. plos.org/plosone/article?id=10.1371/journal.pone.0001612. doi: 10. 1371/journal.pone.000 1612.
|
[7] |
Toker A, Huehn J. To be or not to be a Treg cell: lineage decisions controlled by epigenetic mechanisms[J]. Sci Signal, 2011,4(158):pe4. doi: 10.1126/scisignal.2001783.
|
[8] |
Ozen S, Pistorio A, Iusan SM, et al. EULAR/PRINTO/PRES criteria for Henoch⁃Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria[J]. Ann Rheum Dis, 2010,69(5):798⁃806. doi: 10.1136/ard.2009.116657.
|
[9] |
Luo S, Liang G, Zhang P, et al. Aberrant histone modifications in peripheral blood mononuclear cells from patients with Henoch⁃Schönlein purpura[J]. Clin Immunol, 2013,146(3):165⁃175. doi: 10.1016/j.clim.2012.12.009.
|
[10] |
Yu X, Liang G, Yin H, et al. DNA hypermethylation leads to lower FOXP3 in CD4+ T cells of patients with primary Sjögren′s syndrome[J]. Clin Immunol, 2013,148(2):254⁃257. doi: 10.1016/j.clim.2013.05.005.
|
[11] |
Liao W, Li M, Wu H, et al. Down⁃regulation of MBD4 con⁃tributes to hypomethylation and over of CD70 in CD4+ T cells in systemiclupus erythematosus[J]. Clin Epigenetics, 2017,9:104. doi: 10.1186/s13148⁃017⁃0405⁃8.
|
[12] |
Wang Y, Shu Y, Xiao Y, et al. Hypomethylation and over⁃ of ITGAL (CD11a) in CD4(+) T cells in systemic sclerosis[J]. Clin Epigenetics, 2014,6(1):25. doi: 10.1186/1868⁃7083⁃6⁃25.
|
[13] |
Tselios K, Sarantopoulos A, Gkougkourelas I, et al. CD4+CD25highFOXP3+ T regulatory cells as a biomarker of disease activity in systemic lupus erythematosus: a prospective study[J]. Clin Exp Rheumatol, 2014,32(5):630⁃639.
|
[14] |
Kawashiri SY, Kawakami A, Okada A, et al. CD4+CD25(high)CD127(low/⁃) Treg cell frequency from peripheral blood correlates with disease activity in patients with rheumatoid arthritis[J]. J Rheumatol, 2011,38(12):2517⁃2521. doi: 10.3899/jrheum.110283.
|
[15] |
El⁃Darouti MA, Hegazy RA, Abdel HRM, et al. Study of T helper (17) and T regulatory cells in psoriatic patients receiving live attenuated varicella vaccine therapy in a randomized controlled trial[J]. Eur J Dermatol, 2014,24(4):464⁃469. doi: 10.1684/ejd. 2014.2377.
|
[16] |
Antiga E, Quaglino P, Bellandi S, et al. Regulatory T cells in the skin lesions and blood of patients with systemic sclerosis and morphoea[J]. Br J Dermatol, 2010,162(5):1056⁃1063. doi: 10. 1111/j.1365⁃2133.2010.09633.x.
|